Editorial – ExecEdge

FIGS 4Q Adjusted EBITDA Climbs $6.8 Million

FIGS 4Q Adjusted EBITDA Climbs $6.8 Million

By Daniella Parra FIGS, Inc. (NYSE: FIGS) said fourth quarter net revenue was $144.9 million and a reclassification negatively impacted net revenues by $4.7 million. Gross margin was 67.5%, a decrease of 70 basis points and operating expenses were $83.6...

Vivani Medical Shows Preclinical Data on Weight Loss Implants

Vivani Medical Shows Preclinical Data on Weight Loss Implants

By Daniella Parra Vivani Medical, Inc. (Nasdaq: VANI) reported promising preclinical data on NPM-115, a miniature exenatide implant for chronic weight management. The company focuses on GLP-1 implants for obesity treatment due to their potential to improve patient outcomes, which...

Portillo’s Reports Strong 4Q Revenue, Operating Cash Flow

Portillo’s Reports Strong 4Q Revenue, Operating Cash Flow

By Karen E. Roman Portillo’s Inc. (NASDAQ: PTLO), the casual restaurant known for its Chicago-style favorites menu, reported a 24.5% increase in total revenue for the last quarter of 2023 and a rise of 4.4% on same-restaurant sales. Operating income...

Agilent Technologies Appoints Padraig McDonnell as CEO-Elect

Agilent Technologies Appoints Padraig McDonnell as CEO-Elect

By Daniella Parra Agilent Technologies, Inc. (NYSE: A) announced Padraig McDonnell, president of the Agilent CrossLab Group (ACG), as CEO-elect and chief operating officer, succeeding Mike McMullen, the current President and CEO, who will retire. Agilent said McDonnell has held...

Planet Fitness 4Q, 2023 Revenue Increases on New Stores

Planet Fitness 4Q, 2023 Revenue Increases on New Stores

  By Karen E. Roman Planet Fitness, Inc. (NYSE: PLNT) reported total revenue grew 1.4% on the fourth quarter to $285.1 million and system-wide same store sales rose 7.7%. Adjusted EBITDA grew 7.8% to $114.3 million from $106.1 million the...

Vaxxinity’s Heart Health Innovation to Reduce LDL Cholesterol Levels

Vaxxinity’s Heart Health Innovation to Reduce LDL Cholesterol Levels

By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it demonstrated that VXX-401 lowers LDL cholesterol, supporting its potential for treating hypercholesterolemia. The VXX-401, a synthetic peptide vaccine, aims to provide a safe and effective solution against heart disease by targeting...

Innovation, Especially in Tech, Should Have No Borders

Innovation, Especially in Tech, Should Have No Borders

By Carola McGiffert The U.S. government through successive administrations has sought to keep China from developing and manufacturing advanced technologies. The wisdom of clamping down on freely flowing trade around the world can be debated, but it would be an...

Input your search keywords and press Enter.